|Bid||48.19 x 400|
|Ask||48.20 x 200|
|Day's Range||47.62 - 48.24|
|52 Week Range||36.81 - 50.24|
|PE Ratio (TTM)||11.66|
|Dividend & Yield||1.64 (3.41%)|
|1y Target Est||53.25|
Valeant (VRX) has decided to sell Obagi Medical for $190 million and use the proceeds for reducing down debt.
Novartis reported smaller earnings and revenue declines for Q2 than expected. Johnson & Johnson topped on earnings but fell just shy on revenue.
AstraZeneca plc shares rose after the company reportedly confirmed that its CEO is not quitting the company to join the generic drug-maker, Teva Pharmaceutical Industries Limited (TEVA).